Stephens & Co. Maintains Overweight on Staar Surgical, Lowers Price Target to $57
Portfolio Pulse from richadhand@benzinga.com
Stephens & Co. analyst George Sellers maintains an Overweight rating on Staar Surgical (NASDAQ:STAA) but has lowered the price target from $71 to $57.
August 04, 2023 | 4:23 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Staar Surgical's price target has been lowered from $71 to $57 by Stephens & Co., though the Overweight rating is maintained.
The lowering of the price target by Stephens & Co. indicates a potential decrease in the short-term value of Staar Surgical's stock. However, the maintained Overweight rating suggests that the company is still expected to outperform the market, which could mitigate some of the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100